[
  {
    "ts": null,
    "headline": "Stifel resumes coverage on medtech names, sees long-term diabetes devices growth",
    "summary": "Investing.com -- Stifel has resumed coverage of several medtech companies, citing steady adoption of continuous glucose monitors (CGMs) and insulin pumps as key drivers for growth.",
    "url": "https://finnhub.io/api/news?id=4752f2797a6c6bfdf8c692804338343451b069c74310e290b116711d6a5cf19e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761060477,
      "headline": "Stifel resumes coverage on medtech names, sees long-term diabetes devices growth",
      "id": 137181008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Investing.com -- Stifel has resumed coverage of several medtech companies, citing steady adoption of continuous glucose monitors (CGMs) and insulin pumps as key drivers for growth.",
      "url": "https://finnhub.io/api/news?id=4752f2797a6c6bfdf8c692804338343451b069c74310e290b116711d6a5cf19e"
    }
  }
]